Appelhans D - Search Results

1

Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency.

Schmitz M, Candelise N, Kanata E, Llorens F, Thüne K, Villar-Piqué A, da Silva Correia SM, Dafou D, Sklaviadis T, Appelhans D, Zerr I. Schmitz M, et al. Among authors: appelhans d. Mol Neurobiol. 2020 Apr;57(4):1863-1874. doi: 10.1007/s12035-019-01837-w. Epub 2019 Dec 17. Mol Neurobiol. 2020. PMID: 31848935

2

Internalization and intracellular trafficking of poly(propylene imine) glycodendrimers with maltose shell in melanoma cells.

Filimon A, Sima LE, Appelhans D, Voit B, Negroiu G. Filimon A, et al. Among authors: appelhans d. Curr Med Chem. 2012;19(29):4955-68. doi: 10.2174/0929867311209024955. Curr Med Chem. 2012. PMID: 23033945

3

Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.

Klementieva O, Aso E, Filippini D, Benseny-Cases N, Carmona M, Juvés S, Appelhans D, Cladera J, Ferrer I. Klementieva O, et al. Among authors: appelhans d. Biomacromolecules. 2013 Oct 14;14(10):3570-80. doi: 10.1021/bm400948z. Epub 2013 Sep 26. Biomacromolecules. 2013. PMID: 24004423

4

Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.

Ziemba B, Franiak-Pietryga I, Pion M, Appelhans D, Muñoz-Fernández MÁ, Voit B, Bryszewska M, Klajnert-Maculewicz B. Ziemba B, et al. Among authors: appelhans d. Int J Pharm. 2014 Jan 30;461(1-2):391-402. doi: 10.1016/j.ijpharm.2013.12.011. Epub 2013 Dec 17. Int J Pharm. 2014. PMID: 24361266

5

Potential of Ni(II)-NTA-modified poly(ethylene imine) glycopolymers as carrier system for future dendritic cell-based immunotherapy.

Hauptmann N, Pion M, Wehner R, Muñoz-Fernández MÁ, Schmitz M, Voit B, Appelhans D. Hauptmann N, et al. Among authors: appelhans d. Biomacromolecules. 2014 Mar 10;15(3):957-67. doi: 10.1021/bm401845b. Epub 2014 Feb 13. Biomacromolecules. 2014. PMID: 24499049

6

Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.

Szulc A, Pulaski L, Appelhans D, Voit B, Klajnert-Maculewicz B. Szulc A, et al. Among authors: appelhans d. Int J Pharm. 2016 Nov 20;513(1-2):572-583. doi: 10.1016/j.ijpharm.2016.09.063. Epub 2016 Sep 22. Int J Pharm. 2016. PMID: 27667754

7

Sugar-Modified Poly(propylene imine) Dendrimers Stimulate the NF-κB Pathway in a Myeloid Cell Line.

Jatczak-Pawlik I, Gorzkiewicz M, Studzian M, Appelhans D, Voit B, Pulaski L, Klajnert-Maculewicz B. Jatczak-Pawlik I, et al. Among authors: appelhans d. Pharm Res. 2017 Jan;34(1):136-147. doi: 10.1007/s11095-016-2049-3. Epub 2016 Oct 20. Pharm Res. 2017. PMID: 27766462 Free PMC article.

8

Mechanisms of Internalization of Maltose-Modified Poly(propyleneimine) Glycodendrimers into Leukemic Cell Lines.

Studzian M, Szulc A, Janaszewska A, Appelhans D, Pułaski Ł, Klajnert-Maculewicz B. Studzian M, et al. Among authors: appelhans d. Biomacromolecules. 2017 May 8;18(5):1509-1520. doi: 10.1021/acs.biomac.7b00046. Epub 2017 Apr 25. Biomacromolecules. 2017. PMID: 28414464

9

Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection.

Aso E, Martinsson I, Appelhans D, Effenberg C, Benseny-Cases N, Cladera J, Gouras G, Ferrer I, Klementieva O. Aso E, et al. Among authors: appelhans d. Nanomedicine. 2019 Apr;17:198-209. doi: 10.1016/j.nano.2019.01.010. Epub 2019 Jan 30. Nanomedicine. 2019. PMID: 30708052 Free article.

10

Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.

Franiak-Pietryga I, Ziemba B, Sikorska H, Jander M, Kuncman W, Danilewicz M, Appelhans D, Lewkowicz P, Ostrowska K, Bryszewska M, Borowiec M. Franiak-Pietryga I, et al. Among authors: appelhans d. Toxicol Appl Pharmacol. 2020 Sep 15;403:115139. doi: 10.1016/j.taap.2020.115139. Epub 2020 Jul 17. Toxicol Appl Pharmacol. 2020. PMID: 32687837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page